Keywords: Gastrointestinal cancer; Human Papillomavirus; Epstein - Barr virus; John Cunningham Virus; Cytomegalovirus;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: WHO; World Health Organization; TNF; tumor necrosis factor; IL; interleukin; HSC; hematopoietic stem cell; NSG; NOD/SCID/γcâ/â; NK; natural killer; DC; dendritic cell; TCR; T cell receptor; DTH; delayed type hypersensitivity; HLA; human leukocyte ant
Keywords: AIDS; acquired immunodeficiency virus; ANI; asymptomatic neurocognitive impairment; BBB; blood brain barrier; BDNF; brain derived neurotrophic factor; cART; combination antiretroviral therapy; CDC; Centers for Disease Control and Prevention; CNS; central
Keywords: BBB; blood-brain barrier; CNS; central nervous system; DMF; dimethyl fumarate; DMT; disease-modifying therapy; EDSS; Expanded Disability Status Scale; FDA; Food and Drug Administration; GA; glatiramer acetate; JCV; John Cunningham virus; MRI; magnetic res
Humoral response to John Cunningham virus during pregnancy in multiple sclerosis
Keywords: Multiple sclerosis; Pregnancy; John Cunningham virus; JCV;
Biomarkers identification for PML monitoring, during Natalizumab (Tysabri®) treatment in Relapsing-Remitting Multiple Sclerosis
Keywords: Natalizumab (Tysabri®); Relapsing Remitting Multiple Sclerosis; Progressive Multifocal Leukoencephalopathy; John Cunningham virus; Risk factors; Biomarkers;
Clinical outcomes in patients with relapsing-remitting multiple sclerosis who switch from natalizumab to delayed-release dimethyl fumarate: A multicenter retrospective observational study (STRATEGY)
Keywords: AE; adverse event; ARR; annualized relapse rate; DMF; dimethyl fumarate; DMT; disease-modifying therapy; HR; hazard ratio; IPTW; inverse probability of treatment weight; JCV; John Cunningham virus; MS; multiple sclerosis; PML; progressive multifocal leuko
Progressive multifocal leukoencephalopathy in patients receiving rituximab and cyclophosphamide after haplo-identical T-cell replete transplantation and review of the literature
Keywords: Progressive multifocal leukoencephalopathy; John Cunningham virus; Haploidentical stem cell transplantation; Rituximab;
Original ResearchFull Report: Clinical-Alimentary TractSafety and Efficacy of AJM300, an Oral Antagonist of α4 Integrin, in Induction Therapy for Patients With Active Ulcerative Colitis
Keywords: Integrin; IBD; Randomized Clinical Trial; Lymphocyte Trafficking; CI; confidence interval; IBD; inflammatory bowel disease; JCV; John Cunningham virus; MAdCAM-1; mucosal addressin cell adhesion molecule-1; OR; odds ratio; PML; progressive multifocal leuk
DExD/H-box RNA helicases as mediators of anti-viral innate immunity and essential host factors for viral replication
Keywords: 5â² ppp; 5â² triphosphate; AIM2; Absent In Melanoma 2; ARE; AU-rich element; CARD; Caspase Activation and Recruitment Domains; CDN; cyclic dinucleotide; cGAMP; cyclic-GMP-AMP; cGAS; cGAMP Synthase; CRM1; Chromosome Maintenance Region 1; CstF; Cleavage S
A woman with ataxia, nystagmus and headache
Keywords: HAART; highly active antiretroviral therapy; HIVE; HIV-associated encephalopathy; IRIS; immune reconstitution inflammatory syndrome; JCV; John Cunningham virus; PML; progressive multifocal leukoencephalopathy; TE; toxoplasma encephalitis;